PP&E (Net)
Pfizer PP&E (Net) increased by 0.4% to $19.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $18.35B to $19.40B. Over 5 years (FY 2020 to FY 2025), PP&E (Net) shows an upward trend with a 7.0% CAGR.
Analysis
How to read this metric
An increase indicates ongoing investment in physical capacity, whereas a decline may suggest aging assets or a strategy of asset-light operations.
Detailed definition
This metric represents the book value of tangible assets after subtracting accumulated depreciation from the total histo...
Peer comparison
Standard line item for all manufacturing and industrial companies; directly comparable across peers.
property_plant_equipment_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.22B | $14.44B | $14.88B | $15.11B | $15.24B | $15.44B | $16.27B | $17.05B | $17.49B | $17.86B | $18.94B | $18.80B | $18.96B | $18.54B | $18.39B | $18.35B | $18.78B | $18.88B | $19.32B | $19.40B |
| QoQ Change | — | +1.5% | +3.1% | +1.5% | +0.9% | +1.3% | +5.4% | +4.8% | +2.6% | +2.1% | +6.0% | -0.7% | +0.8% | -2.2% | -0.8% | -0.3% | +2.3% | +0.6% | +2.3% | +0.4% |
| YoY Change | — | — | — | — | +7.2% | +7.0% | +9.4% | +12.9% | +14.7% | +15.7% | +16.4% | +10.3% | +8.4% | +3.8% | -2.9% | -2.4% | -1.0% | +1.8% | +5.0% | +5.8% |
Geographic Breakdown — Developed Europe
| Segment | Q4 '21 | Q4 '22 |
|---|---|---|
| Developed Europe | $5.09B | $5.39B |
| Emerging Markets | $1.06B | $1.41B |
| Developed Rest of World | $347.00M | $293.00M |
| Total | $14.88B | $16.27B |
Developed Europe, Developed Rest of World, Emerging Markets were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Geographic Breakdown — Developed Markets
| Segment | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|
| Developed Markets | $6.71B | $7.19B | $8.18B |
| Emerging Markets | $1.55B | $1.46B | $1.46B |
| Total | $18.94B | $18.39B | $19.32B |
PP&E (Net) at Other Companies
Frequently Asked Questions
- What is Pfizer's pp&e (net)?
- Pfizer (PFE) reported pp&e (net) of $19.40B in Q1 2026.
- How has Pfizer's pp&e (net) changed year-over-year?
- Pfizer's pp&e (net) increased by 5.8% year-over-year, from $18.35B to $19.40B.
- What is the long-term trend for Pfizer's pp&e (net)?
- Over 5 years (2020 to 2025), Pfizer's pp&e (net) has grown at a 7.0% compound annual growth rate (CAGR), from $13.75B to $19.32B.
- What does pp&e (net) mean?
- The current book value of physical assets after accounting for wear and tear.